Skip to main content Skip to content

How TMS for Treatment-Resistant Depression Is Measured Before You Begin

Scroll to read
Back to Resources & Blog
How TMS for Treatment-Resistant Depression Is Measured Before You Begin

A Clear Baseline Can Make Your TMS Treatment More Meaningful

TMS has helped many people with difficult-to-treat depression regain function, energy, and quality of life when standard care has not brought enough relief. Before we recommend TMS for treatment-resistant depression, we begin with a thoughtful baseline evaluation, not assumptions. A starting point gives us a clear picture of what you are experiencing now and what progress would look like in your real life. At Resova Infusions and TMS, our psychiatrist evaluates your symptoms, treatment history, safety needs, and goals before treatment begins. TMS is not effective for every person, and results can vary, but ongoing measurement helps us recognize meaningful changes over time.

Confirming Treatment-Resistant Depression Before TMS

Treatment-resistant depression generally means that depression has not improved enough after appropriate standard treatments. This often includes antidepressant medication trials and psychotherapy when clinically appropriate. Still, the definition is personal. A medication that was too brief, poorly tolerated, or not taken at a therapeutic dose may not tell us the same story as a well-supported treatment trial. During your psychiatric evaluation, we review the full context behind persistent symptoms, including:
  • Previous diagnoses and current symptoms  
  • Medication history, dose, duration, and response  
  • Therapy experience and any past hospitalizations  
  • Sleep problems, anxiety, trauma, substance use, or medical concerns
This review matters because TMS is an FDA-cleared, non-systemic option for major depressive disorder and can be a strong consideration after medication failure. Diagnostic clarity helps us determine whether TMS fits the clinical reason for your symptoms and how it may fit into your broader care plan.

Measuring Symptoms Beyond a Single Depression Score

Standardized depression questionnaires provide a useful starting point, but no single score can fully describe your day-to-day experience. We may use validated tools such as the PHQ-9 along with clinician-guided discussion to understand symptom severity more completely. Depression can affect far more than sadness. Your baseline may include questions about mood, interest in activities, motivation, focus, sleep, appetite, anxiety, irritability, energy, hopelessness, and thoughts of self-harm. If safety concerns are present, we address them directly as part of psychiatric care. Just as important, we ask how symptoms are affecting your ability to live. A lower questionnaire score matters, but improvement may also mean getting through a workday, keeping up with school, reconnecting with family, caring for yourself, or feeling present enough to enjoy a routine again. These real-world markers help us focus TMS treatment on the changes that matter most to you.

Reviewing Safety, History, and TMS Candidacy

TMS is non-sedating and does not circulate through the body like medication, but it still requires psychiatric oversight and careful screening. Before treatment, we review your medical history, current medications, neurological concerns, seizure history, substance use, and any past mania, hypomania, or psychosis that could affect treatment planning. It is also important to tell us about metal or implanted devices in or near your head, as well as relevant surgical history. This can include cochlear implants, clips, stimulators, or other medical devices. Our clinical team reviews this information to determine whether TMS is appropriate or whether more details are needed. We also discuss what treatment can feel like and what risks to consider. Some people experience scalp discomfort or headache. Seizure is a rare risk, which is one reason individualized screening and monitoring matter. Clear information supports informed decisions, without minimizing either the potential benefits or the clinical boundaries of treatment.

Turning Baseline Results Into a Personalized TMS Plan

Baseline findings help us decide whether TMS for treatment-resistant depression is appropriate and what symptoms should receive the closest attention. Your plan may also consider current medications, psychotherapy, and other psychiatric care so treatment is coordinated rather than isolated. TMS commonly involves frequent weekday visits over several weeks. The exact protocol depends on clinical recommendations and the technology being used, but consistency is an important part of the process. Before beginning, it helps to think through practical needs such as work, family responsibilities, transportation, and your ability to attend regularly. Throughout treatment, we repeat symptom measures and clinical check-ins. This allows us to follow early changes, discuss tolerability, and assess the overall response instead of relying on guesswork. Some people experience substantial improvement, while others notice more gradual or limited changes. Ongoing measurement gives us a more honest and useful picture of how treatment is going.

A Thoughtful TMS Evaluation Before Winter

Persistent depression deserves attention before it becomes more disruptive. Autumn can be a useful time to plan ahead for shorter days, holiday demands, and year-end stress, all of which may make mood symptoms harder for some people.

Understand Your Next Treatment Option

At Resova Infusions and TMS, we help patients make informed decisions about advanced depression care. Learn whether TMS for treatment-resistant depression may align with your history, goals, and current treatment needs. Our team provides clear guidance on what the treatment process involves and what to expect throughout care.
A calming clinical backdrop for the contact section

Request an appointment

Start your journey to relief today.

Most patients are seen within 24 hours of their initial consultation. We accept major insurance including Aetna, Blue Cross Blue Shield, Cigna, United Healthcare, and Tricare. TMS and Spravato may be covered for qualifying conditions, depending on your insurance and plan; not every plan covers them, and both require prior authorization. Insurance does not cover ketamine infusions, but it may cover your office visit. Complete the form or call us directly – our team will verify your benefits and schedule your first appointment.

Our board-certified team specializes in ketamine infusion therapy, TMS (Transcranial Magnetic Stimulation), and Spravato treatment for depression, anxiety, PTSD, OCD, and chronic pain. We serve patients throughout Northern Virginia from our Fairfax clinic, including McLean, Vienna, Reston, Arlington, Falls Church, and the greater DC metro area.

During your consultation, Dr. Arora will review your medical history, current symptoms, and previous treatments to determine if interventional psychiatry is right for you. We believe in personalized care – no two treatment plans are exactly alike because no two patients are exactly alike.

Call the clinic
Call us 571-418-8141 ext. 6
Email us infusions@resovahealth.com
Connect with us
(opens in a new tab) (opens in a new tab) (opens in a new tab)
🌿

Ivy

Clinical Care Coordinator
Welcome to Resova Infusions. This secure portal is for scheduling requests and identity verification only. It does not provide medical diagnoses, treatment instructions, or prescriptions. Specialty therapies, including Ketamine infusions, Spravato (esketamine), and TMS (Transcranial Magnetic Stimulation), are strictly clinical procedures requiring comprehensive in-office evaluations and are administered under direct medical supervision; they cannot be prescribed or initiated via chat, though appointments for initial clinical consultations can be requested here. This system is not monitored for psychiatric crises. If you are experiencing an emergency, please call 911, go to the nearest emergency room, or dial 988 immediately.
Please enter your phone number to authenticate: